These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 26962858)

  • 1. Changes in the miRNA-mRNA Regulatory Network Precede Motor Symptoms in a Mouse Model of Multiple System Atrophy: Clinical Implications.
    Schafferer S; Khurana R; Refolo V; Venezia S; Sturm E; Piatti P; Hechenberger C; Hackl H; Kessler R; Willi M; Gstir R; Krogsdam A; Lusser A; Poewe W; Wenning GK; Hüttenhofer A; Stefanova N
    PLoS One; 2016; 11(3):e0150705. PubMed ID: 26962858
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oligodendroglial α-synucleinopathy-driven neuroinflammation in multiple system atrophy.
    Hoffmann A; Ettle B; Battis K; Reiprich S; Schlachetzki JCM; Masliah E; Wegner M; Kuhlmann T; Riemenschneider MJ; Winkler J
    Brain Pathol; 2019 May; 29(3):380-396. PubMed ID: 30444295
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Viral-mediated oligodendroglial alpha-synuclein expression models multiple system atrophy.
    Bassil F; Guerin PA; Dutheil N; Li Q; Klugmann M; Meissner WG; Bezard E; Fernagut PO
    Mov Disord; 2017 Aug; 32(8):1230-1239. PubMed ID: 28556404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reducing C-terminal truncation mitigates synucleinopathy and neurodegeneration in a transgenic model of multiple system atrophy.
    Bassil F; Fernagut PO; Bezard E; Pruvost A; Leste-Lasserre T; Hoang QQ; Ringe D; Petsko GA; Meissner WG
    Proc Natl Acad Sci U S A; 2016 Aug; 113(34):9593-8. PubMed ID: 27482103
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A rapidly progressive multiple system atrophy-cerebellar variant model presenting marked glial reactions with inflammation and spreading of α-synuclein oligomers and phosphorylated α-synuclein aggregates.
    Yamaguchi H; Nishimura Y; Matsuse D; Sekiya H; Masaki K; Tanaka T; Saiga T; Harada M; Kira YI; Dickson DW; Fujishima K; Matsuo E; Tanaka KF; Yamasaki R; Isobe N; Kira JI
    Brain Behav Immun; 2024 Oct; 121():122-141. PubMed ID: 38986725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alterations in Striatal microRNA-mRNA Networks Contribute to Neuroinflammation in Multiple System Atrophy.
    Kim T; Valera E; Desplats P
    Mol Neurobiol; 2019 Oct; 56(10):7003-7021. PubMed ID: 30968343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Absence of alpha-synuclein mRNA expression in normal and multiple system atrophy oligodendroglia.
    Miller DW; Johnson JM; Solano SM; Hollingsworth ZR; Standaert DG; Young AB
    J Neural Transm (Vienna); 2005 Dec; 112(12):1613-24. PubMed ID: 16284907
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeted overexpression of human alpha-synuclein in oligodendroglia induces lesions linked to MSA-like progressive autonomic failure.
    Stemberger S; Poewe W; Wenning GK; Stefanova N
    Exp Neurol; 2010 Aug; 224(2):459-64. PubMed ID: 20493840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progressive striatonigral degeneration in a transgenic mouse model of multiple system atrophy: translational implications for interventional therapies.
    Refolo V; Bez F; Polissidis A; Kuzdas-Wood D; Sturm E; Kamaratou M; Poewe W; Stefanis L; Angela Cenci M; Romero-Ramos M; Wenning GK; Stefanova N
    Acta Neuropathol Commun; 2018 Jan; 6(1):2. PubMed ID: 29298733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurological and neurodegenerative alterations in a transgenic mouse model expressing human alpha-synuclein under oligodendrocyte promoter: implications for multiple system atrophy.
    Shults CW; Rockenstein E; Crews L; Adame A; Mante M; Larrea G; Hashimoto M; Song D; Iwatsubo T; Tsuboi K; Masliah E
    J Neurosci; 2005 Nov; 25(46):10689-99. PubMed ID: 16291942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. α-Synuclein-induced myelination deficit defines a novel interventional target for multiple system atrophy.
    Ettle B; Kerman BE; Valera E; Gillmann C; Schlachetzki JC; Reiprich S; Büttner C; Ekici AB; Reis A; Wegner M; Bäuerle T; Riemenschneider MJ; Masliah E; Gage FH; Winkler J
    Acta Neuropathol; 2016 Jul; 132(1):59-75. PubMed ID: 27059609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microglial activation mediates neurodegeneration related to oligodendroglial alpha-synucleinopathy: implications for multiple system atrophy.
    Stefanova N; Reindl M; Neumann M; Kahle PJ; Poewe W; Wenning GK
    Mov Disord; 2007 Nov; 22(15):2196-203. PubMed ID: 17853477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Viral-based rodent and nonhuman primate models of multiple system atrophy: Fidelity to the human disease.
    Marmion DJ; Rutkowski AA; Chatterjee D; Hiller BM; Werner MH; Bezard E; Kirik D; McCown T; Gray SJ; Kordower JH
    Neurobiol Dis; 2021 Jan; 148():105184. PubMed ID: 33221532
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin resistance and exendin-4 treatment for multiple system atrophy.
    Bassil F; Canron MH; Vital A; Bezard E; Li Y; Greig NH; Gulyani S; Kapogiannis D; Fernagut PO; Meissner WG
    Brain; 2017 May; 140(5):1420-1436. PubMed ID: 28334990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Striatal transplantation for multiple system atrophy--are grafts affected by alpha-synucleinopathy?
    Stefanova N; Hainzer M; Stemberger S; Couillard-Després S; Aigner L; Poewe W; Wenning GK
    Exp Neurol; 2009 Sep; 219(1):368-71. PubMed ID: 19460374
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oligodendroglial alpha-synucleinopathy and MSA-like cardiovascular autonomic failure: experimental evidence.
    Kuzdas D; Stemberger S; Gaburro S; Stefanova N; Singewald N; Wenning GK
    Exp Neurol; 2013 Sep; 247():531-6. PubMed ID: 23399889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A mouse model of adult-onset multiple system atrophy.
    Tanji K; Miki Y; Mori F; Nikaido Y; Narita H; Kakita A; Takahashi H; Wakabayashi K
    Neurobiol Dis; 2019 Jul; 127():339-349. PubMed ID: 30910745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cellular iron deposition patterns predict clinical subtypes of multiple system atrophy.
    Lee S; Martinez-Valbuena I; Lang AE; Kovacs GG
    Neurobiol Dis; 2024 Jul; 197():106535. PubMed ID: 38761956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alpha-synuclein mRNA expression in oligodendrocytes in MSA.
    Asi YT; Simpson JE; Heath PR; Wharton SB; Lees AJ; Revesz T; Houlden H; Holton JL
    Glia; 2014 Jun; 62(6):964-70. PubMed ID: 24590631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alpha-synuclein transgenic mice: relevance to multiple system atrophy.
    Fillon G; Kahle PJ
    Mov Disord; 2005 Aug; 20 Suppl 12():S64-6. PubMed ID: 16092093
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.